Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization

Last updated: July 1, 2021
Sponsor: Université de Reims Champagne-Ardenne
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04869735
2021-003-Info-Vac
  • Ages 25-25
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The aim of vaccination is to protect the patient against disease by stimulating his immune system. DTPolio is a tetravalent vaccine providing protection against pertussis, diphtheria, tetanus and polio.

In France, the vaccination schedule sets the vaccination recommendations applicable to people according to their age. In this schedule, a booster of DTPolio at the age of 25 is recommended.

The vaccination coverage for patients over 16 years of age is insufficient in France.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • aged 25 years old in 2020
  • without delivery of DTPolio vaccine in 2019 or 2020

Exclusion

Exclusion Criteria:

  • None

Study Design

Total Participants: 2125
Study Start date:
June 04, 2021
Estimated Completion Date:
September 01, 2022

Study Description

The aim of the study is to evaluate impact of information about booster vaccination against DTPolio at 25 years on this booster vaccination's realization.

Connect with a study center

  • Université de Reims Champagne-Ardenne

    Reims,
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.